Consensus-based clinical and research recommendations for use of glucagon-like peptide-1 receptor agonists in the context of eating disorders: a modified Delphi study.
World psychiatry : official journal of the World Psychiatric Association (WPA) · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
Come citare questo studio
Aaron Keshen, Elena Koning, Kelly C Allison, Anastassia Amaro, Sara Bartel, Pauline Belliveau, Lisa Boniferro, Simran Brar, Sonia Butalia, Cynthia M Bulik, Ariana M Chao, Jennifer Couturier, Kimberly Dennis, Laura Dixon, Deena El-Ziftawi, Chloe Gao, Susan Gamberg, Anthony P Goldstone, Riccardo Dalle Grave, Anna I Guerdjikova, Tanya M Halliday, Margaret Hahn, Anastasia Harris, Hubertus Himmerich, William B Horton, Monique Jericho, Brooke Langman, Amanda Lightbody, Diane A Klein, Laurel E S Mayer, Susan L McElroy, Michael Mindrum, Nicholas C Peiper, Colby Price, Amanda Raffoul, Jesse Richards, Lauren M Schaefer, Joanna Steinglass, Valerie H Taylor, Beverly G Tchang, Nami Trappenberg, B Timothy Walsh, Michael A Weintraub, Ashley White, Susan Wnuk. (2026). Consensus-based clinical and research recommendations for use of glucagon-like peptide-1 receptor agonists in the context of eating disorders: a modified Delphi study.. World psychiatry : official journal of the World Psychiatric Association (WPA). DOI: 10.1002/wps.70096
Consulta la pubblicazione originale ↗